Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients

Immunobiology

Volumn 217, Issue 6, 2012, Pages 634-642

  Candia, Enzo ^a   Díaz Jiménez, David ^a   Langjahr, Patricia ^a   Núñez, Lucía E ^a   de la Fuente, Marjorie ^a   Farfán, Nancy ^a   López Kostner, Francisco ^b   Abedrapo, Mario ^c   Alvarez Lobos, Manuel ^d   Pinedo, George ^d   Beltrán, Caroll J ^c   González, Carlos ^e   González, María Julieta ^a   Quera, Rodrigo ^b   Hermoso, Marcela A ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b CLÍNICA LAS CONDES   (Chile)

^c HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^e UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

Inflammatory bowel diseases; Monocytes; Toll like receptor 2; Ulcerative colitis

Indexed keywords

CD33 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; MESSENGER RNA; TOLL LIKE RECEPTOR 2;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CELL POPULATION; COLON CROHN DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; INTESTINE BIOPSY; INTESTINE MUCOSA; LAMINA PROPRIA; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MONONUCLEAR CELL; MUCOSAL IMMUNITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TOLL LIKE RECEPTOR 2 GENE; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELL MOVEMENT; CHEMOKINE CX3CL1; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MUCOUS MEMBRANE; RECEPTORS, CHEMOKINE; SIALIC ACID BINDING IG-LIKE LECTIN 3; SOLUBILITY; TISSUE CULTURE TECHNIQUES; TOLL-LIKE RECEPTOR 2;

EID: 84860253869     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.10.023     Document Type: Article

References (53)

1. Arancibia S., Benitez D., Nuñez L.E., Jewell C.M., Langjhar P., et al. Phosphatidylinositol 3-kinase interacts with the glucocorticoid receptor upon TLR2 activation. J. Cell. Mol. Med. 2011, 15:339-349.
2. Baumgart D.C., Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640.
3. Beltran C.J., Nuñez L.E., Diaz-Jimenez D., Farfan N., Candia E., et al. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 2010, 16:1097-1107.
4. Berglund M., Melgar S., Kobayashi K.S., Flavell R.A., Hornquist E.H., Hultgren O.H. IL-1 receptor-associated kinase M downregulates DSS-induced colitis. Inflamm. Bowel Dis. 2010, 16:1778-1786.
5. Bull D.M., Bookman M.A. Isolation and functional characterization of human intestinal mucosal lymphoid cells. J. Clin. Invest. 1977, 59:966-974.
6. Burns K., Janssens S., Brissoni B., Olivos N., Beyaert R., Tschopp J. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 2003, 197:263-268.
7. Campos N., Magro F., Castro A.R., Cabral J., Rodrigues P., et al. Macrophages from IBD patients exhibit defective tumour necrosis factor-alpha secretion but otherwise normal or augmented pro-inflammatory responses to infection. Immunobiology 2011, 216:961-970.
8. Cario E. Barrier-protective function of intestinal epithelial Toll-like receptor 2. Mucosal Immunol. 2008, 1(Suppl. 1):S62-S66.
9. Cario E., Brown D., McKee M., Lynch-Devaney K., Gerken G., Podolsky D.K. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am. J. Pathol. 2002, 160:165-173.
10. Cario E., Podolsky D.K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 2000, 68:7010-7017.
11. Daperno M., D'Haens G., Van Assche G., Baert F., Bulois P., et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest. Endosc. 2004, 60:505-512.
12. Díaz-Jiménez D., Núñez L.E., Beltrán C.J., Candia E., Suazo C., et al. Soluble ST2: a new and promising activity marker in ulcerative colitis. World J. Gastroenterol. 2011, 17:2181-2190.
13. Dulay A.T., Buhimschi C.S., Zhao G., Oliver E.A., Mbele A., et al. Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. J. Immunol. 2009, 182:7244-7253.
14. Figueroa C., Peralta A., Herrera L., Castro P., Gutierrez A., et al. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease. Eur. Cytokine Netw. 2006, 17:125-130.
15. Franchimont D., Vermeire S., El Housni H., Pierik M., Van Steen K., et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004, 53:987-992.
16. Gomes P., du Boulay C., Smith C.L., Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986, 27:92-95.
17. Gonzalez C., Abello P., Cepeda R., Salazar L., Aravena O., et al. Inflammation, synovial angiogenesis and chondroid apoptosis in the evolution of type II collagen-induced arthritis. Eur. Cytokine Netw. 2007, 18:127-135.
18. Gonzalez S., Aguilera S., Alliende C., Urzua U., Quest A.F., et al. Alterations in type I hemidesmosome components suggestive of epigenetic control in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum. 2011, 63:1106-1115.
19. Hausmann M., Kiessling S., Mestermann S., Webb G., Spottl T., et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002, 122:1987-2000.
20. Henckaerts L., Pierik M., Joossens M., Ferrante M., Rutgeerts P., Vermeire S. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut 2007, 56:1536-1542.
21. Junker Y., Bode H., Wahnschaffe U., Kroesen A., Loddenkemper C., et al. Comparative analysis of mononuclear cells isolated from mucosal lymphoid follicles of the human ileum and colon. Clin. Exp. Immunol. 2009, 156:232-237.
22. Kamada N., Hisamatsu T., Okamoto S., Chinen H., Kobayashi T., et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J. Clin. Invest. 2008, 118:2269-2280.
23. Kobayashi K., Hernandez L.D., Galan J.E., Janeway C.A., Medzhitov R., Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002, 110:191-202.
24. Kobayashi T., Okamoto S., Iwakami Y., Nakazawa A., Hisamatsu T., et al. Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflamm. Bowel Dis. 2007, 13:837-846.
25. Kostadinova F.I., Baba T., Ishida Y., Kondo T., Popivanova B.K., Mukaida N. Crucial involvement of the CX3CR1-CX3CL1 axis in dextran sulfate sodium-mediated acute colitis in mice. J. Leukoc. Biol. 2010, 88:133-143.
26. Kuroishi T., Tanaka Y., Sakai A., Sugawara Y., Komine K., Sugawara S. Human parotid saliva contains soluble toll-like receptor (TLR) 2 and modulates TLR2-mediated interleukin-8 production by monocytic cells. Mol. Immunol. 2007, 44:1969-1976.
27. LeBouder E., Rey-Nores J.E., Rushmere N.K., Grigorov M., Lawn S.D., et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol. 2003, 171:6680-6689.
28. Lewis J.D., Chuai S., Nessel L., Lichtenstein G.R., Aberra F.N., Ellenberg J.H. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm. Bowel Dis. 2008, 14:1660-1666.
29. Li M., Carpio D.F., Zheng Y., Bruzzo P., Singh V., et al. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 2001, 166:7128-7135.
30. Nishida Y., Murase K., Isomoto H., Furusu H., Mizuta Y., et al. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Hepatogastroenterology 2002, 49:678-682.
31. Nishimura M., Kuboi Y., Muramoto K., Kawano T., Imai T. Chemokines as novel therapeutic targets for inflammatory bowel disease. Ann. N.Y. Acad. Sci. 2009, 1173:350-356.
32. Pierik M., Joossens S., Van Steen K., Van Schuerbeek N., Vlietinck R., et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel Dis. 2006, 12:1-8.
33. Podolsky D.K. Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am. J. Physiol. 1999, 277:G495-G499.
34. Putnins E.E., Sanaie A.R., Wu Q., Firth J.D. Induction of keratinocyte growth factor 1. Expression by lipopolysaccharide is regulated by CD-14 and toll-like receptors 2 and 4. Infect. Immun. 2002, 70:6541-6548.
35. Raby A.C., Le Bouder E., Colmont C., Davies J., Richards P., et al. Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. J. Immunol. 2009, 183:506-517.
36. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
37. Rogler G., Hausmann M., Vogl D., Aschenbrenner E., Andus T., et al. Isolation and phenotypic characterization of colonic macrophages. Clin. Exp. Immunol. 1998, 112:205-215.
38. Rugtveit J., Brandtzaeg P., Halstensen T.S., Fausa O., Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994, 35:669-674.
39. Sanale A.R., Firth J.D., Uitto V.J., Putnins E.E. Keratinocyte growth factor (KGF)-1 and -2 protein and gene expression in human gingival fibroblasts. J. Periodontal Res. 2002, 37:66-74.
40. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 2005, 19(Suppl A):5-36.
41. Sipponen T., Nuutinen H., Turunen U., Farkkila M. Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD. Inflamm. Bowel Dis. 2010, 16:2131-2136.
42. Smith P.D., Smythies L.E., Shen R., Greenwell-Wild T., Gliozzi M., Wahl S.M. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol. 2011, 4:31-42.
43. Smythies L.E., Sellers M., Clements R.H., Mosteller-Barnum M., Meng G., et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 2005, 115:66-75.
44. Srinivasan M., Kodumudi K.N., Zunt S.L. Soluble CD14 and toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome. Clin. Immunol. 2008, 126:31-37.
45. Szebeni B., Veres G., Dezsofi A., Rusai K., Vannay A., et al. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin. Exp. Immunol. 2008, 151:34-41.
46. Tanaka K. Expression of Toll-like receptors in the intestinal mucosa of patients with inflammatory bowel disease. Exp. Rev. Gastroenterol. Hepatol. 2008, 2:193-196.
47. Tuller T., Kupiec M., Ruppin E. Determinants of protein abundance and translation efficiency in S. cerevisiae. PLoS Comput. Biol. 2007, 3:e248.
48. van Furth R., Raeburn J.A., van Zwet T.L. Characteristics of human mononuclear phagocytes. Blood 1979, 54:485-500.
49. van Tol E.A., Holt L., Li F.L., Kong F.M., Rippe R., et al. Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts. Am. J. Physiol. 1999, 277:G245-G255.
50. Viswanath V., Myles A., Dayal R., Aggarwal A. Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathicarthritis. J. Rheumatol. 2011, 38:2482-2487.
51. Vogel C., de Sousa Abreu R., Ko D., Le S.Y., Shapiro B.A., et al. Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol. Syst. Biol. 2010, 6:1-9.
52. Zhang G., Ghosh S. Negative regulation of toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 2002, 277:7059-7065.
53. Zheng M., Klinman D.M., Gierynska M., Rouse B.T. DNA containing CpG motifs induces angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:8944-8949.